Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02165735 · ClinicalTrials.gov registry record · NA
Get Ready And Empowered About Treatment
A NA study of HIV, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 2
- Study locations
NCT02165735: Completed NA study of HIV, sponsored by University of Rochester.
NCT02165735 is a NA study of HIV that has completed, run by University of Rochester. The registered enrollment target is 360 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (18% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02165735, a NA study of HIV, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to rigorously assess a program designed to empower patient living with HIV, to improve their health care and health, and to reduce disparities.
Primary Outcome
Our primary outcome measure is patient empowerment based on changes in the Patient Activation Measure or PAM. The Patient Activation Measure (PAM) is a 13-item measure that assesses patient knowledge, skill, and confidence for self-management. People who score high on the PAM normally understand the importance of taking an active role in managing their health and have the skills and confidence to do so.The scores for the 13-item measure range in value from 0-100, with higher scores indicating gr
Conditions Studied
Interventions
- OTHER Usual care
- BEHAVIORAL patient activation training
Study Locations (2)
New York
- Clinical Directors Network - New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2014-08-20 |
| Est. Completion | 2017-02-28 |
| Phase | NA |
What the finished NCT02165735 record still lists
NCT02165735 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (18% lower).
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT02165735 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02165735 about?
NCT02165735 is a clinical study titled "Get Ready And Empowered About Treatment". The purpose of this study is to rigorously assess a program designed to empower patient living with HIV, to improve their health care and health, and to reduce disparities.
What is the current status of trial NCT02165735?
This trial is currently completed. It is a NA study. The enrollment target is 360 participants. The study started on 2014-08-20. Estimated completion is 2017-02-28.
What conditions does trial NCT02165735 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT02165735?
The interventions under investigation include: Usual care (OTHER), patient activation training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02165735?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02165735 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02165735's enrollment target sits among peer trials
360 54th of 303 higher than 248 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI